265 related articles for article (PubMed ID: 4277490)
1. Further studies on the mode of action of psychotomimetic drugs: antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine.
Bradley PB; Briggs I
Br J Pharmacol; 1974 Mar; 50(3):345-54. PubMed ID: 4277490
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25.
Boakes RJ; Bradley PB; Briggs I; Dray A
Br J Pharmacol; 1970 Oct; 40(2):202-18. PubMed ID: 5492893
[TBL] [Abstract][Full Text] [Related]
3. Actions of serotonin and related substances on single neurons in the brain.
Bradley PB; Briggs I
Adv Biochem Psychopharmacol; 1974; 10():159-66. PubMed ID: 4527120
[No Abstract] [Full Text] [Related]
4. Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action.
Commissaris RL; Davis M
Neurosci Biobehav Rev; 1982; 6(4):515-20. PubMed ID: 6817240
[TBL] [Abstract][Full Text] [Related]
5. The effects of methylated tryptamine derivatives on brain stem neurones.
Briggs I
Br J Pharmacol; 1972 May; 45(1):177P-178P. PubMed ID: 5041491
[No Abstract] [Full Text] [Related]
6. Antagonism by LSD to effects of 5-HT on single neurones.
Boakes RJ; Bradley PB; Briggs I; Dray A
Brain Res; 1969 Oct; 15(2):529-31. PubMed ID: 5344384
[No Abstract] [Full Text] [Related]
7. Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine.
Halaris AE
Neurosci Biobehav Rev; 1982; 6(4):483-7. PubMed ID: 6294571
[TBL] [Abstract][Full Text] [Related]
8. Excitation and depression of cortical neurones by 5-hydroxytryptamine.
Roberts MH; Straughan DW
J Physiol; 1967 Nov; 193(2):269-94. PubMed ID: 6065878
[TBL] [Abstract][Full Text] [Related]
9. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
11. A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.
Helsley S; Fiorella D; Rabin RA; Winter JC
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):649-63. PubMed ID: 9682278
[TBL] [Abstract][Full Text] [Related]
12. Excitatory responses of neurones in rat bulbar reticular formation to bulbar raphe stimulation and to iontophoretically applied 5-hydroxytryptamine, and their blockade by LSD 25.
Briggs I
J Physiol; 1977 Feb; 265(2):327-40. PubMed ID: 850197
[TBL] [Abstract][Full Text] [Related]
13. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
[TBL] [Abstract][Full Text] [Related]
14. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
Fantegrossi WE; Harrington AW; Kiessel CL; Eckler JR; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Pharmacol Biochem Behav; 2006 Jan; 83(1):122-9. PubMed ID: 16460788
[TBL] [Abstract][Full Text] [Related]
15. Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive-compulsive disorder.
Zghoul T; Blier P
Int J Neuropsychopharmacol; 2003 Mar; 6(1):13-21. PubMed ID: 12899732
[TBL] [Abstract][Full Text] [Related]
16. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Rickli A; Moning OD; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
[TBL] [Abstract][Full Text] [Related]
17. The intracranial injection of drug in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity.
Abramson HA; Gettner HH; Carone PA; Rolo A; Krinsky L
J Asthma Res; 1979 Jan; 16(2):55-61. PubMed ID: 287665
[TBL] [Abstract][Full Text] [Related]
18. [N,N-dimethyltryptamine: first comparative results. Preliminary communication].
Arnold OH
Arzneimittelforschung; 1975 Jun; 25(6):972-4. PubMed ID: 1057950
[TBL] [Abstract][Full Text] [Related]
19. Neurophysiological effects of hallucinogens on serotonergic neuronal systems.
McCall RB
Neurosci Biobehav Rev; 1982; 6(4):509-14. PubMed ID: 7177511
[TBL] [Abstract][Full Text] [Related]
20. Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats.
Walters JK; Sheard MH; Davis M
Pharmacol Biochem Behav; 1978 Jul; 9(1):87-90. PubMed ID: 279938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
